Delphine Diagnostics partners with Rutgers Business School on an impactful project

Delphine Diagnostics partners with Rutgers Business School on an impactful project

New Brunswick, NJ. July 2024: 

As a part of the Industry Client Project course at Rutgers Business School, Delphine Diagnostics has been working with talented students looking to make a real-world impact in the Biotechnology and Medical Devices space. It has been great to offer this opportunity for collaboration and to gather valuable and actionable insights.

The Delphine Team worked closely with the students to provide guidance and mentorship throughout the semester. Alfred D’lorio (CFO), Andy Bala (CEO),  and Mary Stack (Scientist) took the lead on this project.

Jesse Chao, PharmD is a pharmacist who has nearly 10 years of experience in the biopharmaceutical industry. He started his career in Pharmacovigilance/Risk Management and eventually transitioned to clinical development. He is currently a clinical scientist at Regeneron Pharmaceuticals working on allergy/immunology drug development. He anticipates completion of the MBA program at Rutgers Business School in August 2024.

Emily O’Neill, PharmD, RPh is a pharmacist with five years of experience in the Pharmaceutical Industry. She started her career as a postdoctoral fellow with Rutgers/Bristol Myers Squibb and is now a Cardiovascular Pricing and Access Strategy Lead at Bristol Myers Squibb. Emily is in her final semester of the MBA program at Rutgers Business School.

Jaime Rochotte is in the Masters of Supply Chain Analytics Program at Rutgers Business School and has almost 8 years of experience in the logistics industry. She is currently an Inventory Control Analyst at BevDS analyzing inventory levels and recording and reporting the variety pack production done on-site.

A big thank you to Professor Joe Agresta for his constant support. Wishing these students the very best of luck and bright futures ahead!